(Q44784716)

English

Eradication of a large MOPC-315 tumor in athymic nude mice by chemoimmunotherapy with Lyt2+ splenic T cells from melphalan-treated BALB/c mice bearing a large MOPC-315 tumor

scientific article published in January 1990

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 December 2017

Eradication of a large MOPC-315 tumor in athymic nude mice by chemoimmunotherapy with Lyt2+ splenic T cells from melphalan-treated BALB/c mice bearing a large MOPC-315 tumor (English)

1 reference

Europe PubMed Central

6 December 2017

author name string

L M Weiskirch

1

1 reference

Europe PubMed Central

6 December 2017

E Barker

2

1 reference

Europe PubMed Central

6 December 2017

M B Mokyr

3

1 reference

Europe PubMed Central

6 December 2017

publication date

1 January 1990

1 reference

Europe PubMed Central

6 December 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

6 December 2017

31

1 reference

Europe PubMed Central

6 December 2017

3

1 reference

Europe PubMed Central

6 December 2017

129-138

1 reference

Europe PubMed Central

6 December 2017

https://scigraph.springernature.com/pub.10.1007/bf01744726

0 references

Modification of tumor regression by immunologic means

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specificity of cytotoxic T cells from athymic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Melphalan-mediated potentiation of antitumor immune responsiveness of immunosuppressed spleen cells from mice bearing a large MOPC-315 tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increase in the effectiveness of melphalan therapy with progression of MOPC-315 plasmacytoma tumor growth.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired clonal expansion in athymic nude CD8+CD4- T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Down-regulation of the antitumor immune response.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specificity of the generation and expression of enhanced anti-plasmacytoma immunity by spleen cells from melphalan-treated MOPC-315 tumor bearers

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Importance of Lyt 2+ T-cells in the curative effectiveness of a low dose of melphalan for mice bearing a large MOPC-315 tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxazaphosphorines as biological response modifiers--experimental and clinical perspectives

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Melphalan-induced enhancement of tumor cell immunostimulatory capacity as a mechanism for the appearance of potent antitumor immunity in the spleen of mice bearing a large metastatic MOPC-315 tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Importance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Athymic nude CD4+8- T cells produce IL-2 but fail to proliferate in response to mitogenic stimuli

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective effects of Adriamycin on murine host defense systems

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmentation of host antitumor immunity by low doses of cyclophosphamide and mafosfamide in two animal tumor models

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of Murine Leukemia Chemotherapy According to the Immune State: Reconsideration of Correlations Between Chemotherapy, Tumour Cell Killing, and Survival Time

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Melphalan-induced appearance of potent antitumor immune reactivity in tumor bearer lymphocytes co-expressing the Lyt 2 and the L3T4 antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Importance of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recruitment and activation of tumor-specific immune T cells in situ. CD8+ cells predominate the secondary response in sponge matrices and exert both delayed-type hypersensitivity-like and cytotoxic T lymphocyte activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro induction of tumour-specific immunity. I. Development of optimal conditions for induction and assay of cytotoxic lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Some advantages of curing mice bearing a large subcutaneous MOPC-315 tumor with a low dose rather than a high dose of cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immunosuppression

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumour necrosis factor production by IL-2-activated macrophages in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of antitumor immunity in cyclophosphamide-induced rejection of subcutaneous nonpalpable MOPC-315 tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cooperation between cyclophosphamide tumoricidal activity and host antitumor immunity in the cure of mice bearing large MOPC-315 tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2337902

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01744726

1 reference

Europe PubMed Central

6 December 2017

1 reference

Europe PubMed Central

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44784716&oldid=2041123575"